首页> 外国专利> PHARMACEUTICAL COMPOSITION OF ANTIBIOTICS AND prebiotics FOR PREVENTION AND TREATMENT OF DYSBIOSE IN ANTIBACTERIAL THERAPY

PHARMACEUTICAL COMPOSITION OF ANTIBIOTICS AND prebiotics FOR PREVENTION AND TREATMENT OF DYSBIOSE IN ANTIBACTERIAL THERAPY

机译:抗生素和益生元的药物组合物,用于预防和治疗抗生素治疗中的恶心症

摘要

The invention relates to medicine and pharmacology, in particular to pharmaceutical compositions containing the following antimicrobial preparations: antibiotics and sulphanylamides combined with prebiotic in the form of a lactulose. The composition is used for preventing enteral dysbiosis arising during antibiotic therapy using the wide range of preparations. The inventive phamaceutical composition contains antibiotic or a sulphanylamide preparation and lactulose, wherein the antibiotic particle size ranges form 20 to 160 mkm, the sulphanylamide preparation particle size ranges from 40 to 150 mkm and the lactulose has a particle size equal to or less than 0.3 mm and the purity of at least 97 %, with the ratio of the antibiotic and lactulose ranging from 1:0.1 to 1:100, and the ratio of the sulphanylamide preparation and lactulose of 1:12, said composition being internally administered. The inventive preparations contribute to the preservation of antibiotic-damaged intestinal flora by producing selective prebiotic action on the growth of dominant types of microflora of the large intestine,such as lactobacilli and bifidobacteria.
机译:本发明涉及医学和药理学,尤其涉及含有以下抗微生物制剂的药物组合物:抗生素和磺酰胺类化合物与乳果糖形式的益生元组合。该组合物用于预防使用多种制剂的抗生素治疗过程中引起的肠营养不良。本发明的药物组合物包含抗生素或亚磺酰胺制剂和乳果糖,其中抗生素的粒度范围为20至160mkm,亚磺酰胺制剂的粒​​度为40至150mkm,乳果糖的粒度等于或小于0.3mm所述组合物是内部给药的,并且纯度至少为97%,抗生素和乳果糖的比例为1:0.1至1:100,并且磺酰胺制剂和乳果糖的比例为1:12。本发明的制剂通过对大肠的主要类型的菌群例如乳杆菌和双歧杆菌的生长产生选择性的益生元作用,从而有助于保护被抗生素破坏的肠菌群。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号